MARC details
000 -LEADER |
fixed length control field |
04294namaa22004211i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - أخر تعامل مع التسجيلة |
control field |
20241010161421.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
240928s2023 |||a|||f |m|| 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloguing agency |
EG-GICUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GICUC |
Modifying agency |
EG-GICUC |
Description conventions |
rda |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
Language code of summary or abstract |
eng |
-- |
ara |
049 ## - Acquisition Source |
Acquisition Source |
Deposit |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
618.1 |
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
Classification number |
618.1 |
Edition number |
21 |
097 ## - Degree |
Degree |
M.Sc |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Local Call Number |
Cai01.11.15.M.Sc.2023.El.C. |
100 0# - MAIN ENTRY--PERSONAL NAME |
Authority record control number or standard number |
Elsayed Fekry Elsayed Omran, |
Preparation |
preparation. |
245 10 - TITLE STATEMENT |
Title |
Comparative Study Between Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women at or Beyond Completed 41 Weeks / |
Statement of responsibility, etc. |
By Elsayed Fekry Elsayed Omran; Under Supervision of DR. Heba Aly El Sawah, DR. Marwa Fouad Sharaf, DR. Mahmoud Ahmed Ismail AbdElhameed |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
دراسة الفرق بين إعطاء عقار الميزوبروستول بالفم أو بالمهبل لتحريض الولادة في السيدات اللاتي لم ينجبن من قبل وأتممن 41 أسبوع من الحمل / |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
2023. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
73 pages : |
Other physical details |
illustrations ; |
Dimensions |
25 cm. + |
Accompanying material |
CD. |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rda content |
337 ## - MEDIA TYPE |
Media type term |
Unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (M.Sc.) -Cairo University, 2023. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Bibliography: pages 63-73. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Background: Although, vaginal application of misoprostol has been <br/>validated as a reasonable mean of induction, there is a patient resistance to <br/>digital examination and there is a risk of ascending infection. So, oral <br/>administration of misoprostol for labor induction was tried. <br/>Aim and objectives: To compare efficacy and safety of vaginal <br/>misoprostol with oral misoprostol for induction of labor in <br/>nulliparouspregnantwomenatorbeyondcompleted41weeks. <br/>Subjects and methods: Eighty nulliparous pregnant women who were <br/>candidate for labor induction at or beyond completed 41 weeks divided into <br/>two groups: (Group 1):40 pregnant women who received vaginal <br/>misoprostol in a dose of 25μg and repeated every 6 hours if no response <br/>was achieved with a maximum of 4 doses, (Group 2):40 pregnant women <br/>who received oral misoprostol in a dose of 25μg and repeated every 6 hours <br/>if no response was achieved with a maximum of 4 doses. <br/>Results: There was no statistically significant difference between oral& <br/>vaginal misoprostol regarding induction to active stage of labor, induction <br/>to delivery interval, cesarean deliveries, number of doses needed, maternal <br/>or neonatal complications. On the other hand, oxytocin augmentation was <br/>significantly lower in the vaginal group. <br/>Conclusion: 25 mg orally administered misoprostol is similarly effective <br/>& safe as 25 mg vaginal misoprostol to induce labor in nulliparous women <br/>with an unripe cervix at or beyond completed 41weeks. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
كانت الحاجة لزيادة تحفيز المخاض باستخدام الأوكسيتوسين أعلى بشكل يعتد به في مجموعة الميزوبروستول الفموى بالمقارنة مع مجموعة الميزوبروستول المهبلى. إن تناول 25 ملغ من الميزوبروستول عن طريق الفم فعالة وآمنة بشكل مشابه مثل تناول 25 ملغ من الميزوبروستول عن طريق المهبل للحث على المخاض عند النساء اللاتي لم ينجبن من قبل وأتممن 41 أسبوعًا من الحمل. ومع ذلك، وُجد أن الحاجة إلى تحفيز المخاض باستخدام الأوكسيتوسين أعلى لدى النساء اللائي استخدمن الميزوبروستول الفموي |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Issues CD |
Issued also as CD |
546 ## - LANGUAGE NOTE |
Text Language |
Text in English and abstract in Arabic & English. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Obstetrics and Gynecology |
Source of heading or term |
qrmak |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Vaginal misoprostol |
-- |
Oral misoprostol |
-- |
Labor induction |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Heba Aly El Sawah |
Relator term |
thesis advisor. |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Marwa Fouad Sharaf |
Relator term |
thesis advisor. |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mahmoud Ahmed Ismail AbdElhameed |
Relator term |
thesis advisor. |
900 ## - Thesis Information |
Grant date |
01-01-2023 |
Supervisory body |
Heba Aly El Sawah |
-- |
Marwa Fouad Sharaf |
-- |
Mahmoud Ahmed Ismail AbdElhameed |
Universities |
Cairo University |
Faculties |
Faculty of Medicine |
Department |
Department of Obstetrics and Gynecology |
905 ## - Cataloger and Reviser Names |
Cataloger Name |
Nourhan |
Reviser Names |
Huda |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |
Edition |
21 |
Suppress in OPAC |
No |